Areas of Expertise
  • Anemia
  • Thalassemia
  • Leukemia
  • Lymphoma
  • Myeloma
  • Chronic myeloproliferative diseases
  • Chronic myeloid leukemia
  • Coagulation disorders

Education and Specialty Training

  • Ankara University Faculty of Medicine – Medical Education

  • Ankara Numune Training and Research Hospital – Specialty Training in Internal Medicine and Hematology

Professional Experience

  • 2003–2007: Ankara Numune Training and Research Hospital, Hematology

  • 2007–2009: Dr. Abdurrahman Yurtarslan Ankara Oncology Training and Research Hospital, Hematology

  • 2010–2011: Ankara Bayındır Hospital, Bone Marrow Transplant Unit

  • 2011–2016: Turgut Özal University, Hematology

  • 2017–Present: Medical Park Samsun Hospital

Professional Memberships

  • Turkish Society of Internal Medicine Specialists

  • Turkish Society of Hematology

  • Hematology Specialty Association

  • International Society of Hematology

  • European Hematology Association

Articles Published in International Peer-Reviewed Journals

  • Balçik, O.S., Oztürk, M., Dağli, M., Kaftan, O., Koşar, A., Karaaslan, Y., Kirazli, S., "Increased erythropoietin levels in reactive thrombocytosis,” Haematologia (Budap), 32(1), 59-65 (2002). (Indexed in SCI-Expanded)

  • Kaftan, O., Balcik, O.S., Cipil, H., Ozet, G., Bavbek, N., Koşar, A., Dagdas, S., "Plasma levels of thrombin-activatable fibrinolysis inhibitor in primary and secondary thrombocytosis,” Clin Appl Thromb Hemost, 11(4), 449-54 (2005). (Indexed in SCI-Expanded)

  • Balçık, O.Ş., Dağdaş, S., Güler, S.K., Özet, G., Oymak, A., Çelik, Z., Zengin, N., Öksüzoğlu, B., Aylı, M., Dinçer, S., Albayrak, M., “Effect of autologous peripheral stem cell collection regimens on CD34(+) cell count: Single-center experience,” Turkiye Klinikleri J Med Sci, 28, 640-7 (2008). (Indexed in SCI-Expanded)

  • Yokus, O., Albayrak, M., Balcik, O.S., Ceran, F., Dagdas, S., Yilmaz, M., Ozet, G., "Risk factors for thrombophilia in young adults presenting with thrombosis,” Int J Hematol, 90(5), 583-90 (2009). (Indexed in SCI-Expanded)

  • Aydin, Y., Berker, D., Ustün, I., Balcik, O., Balli, D.N., Delibasi, T., Peksoy, I., Guler, S., "A very rare cause of aplastic anemia: Graves disease,” South Med J, 101(6), 666-7 (2008). (Indexed in SCI-Expanded)

  • Balçık, Ö.Ş., Dağdaş, S., Albayrak, M., Efe, C., Yokuş, O., Ceran, F., Özet, G., Yılmaz, M., Albayrak, L., "Development of multiple myeloma during chronic lymphocytic leukemia: Case report,” International Journal of Hematology and Oncology, 18(4), 238-41 (2008). (Indexed in SCI-Expanded)

  • Balçık, Ö.Ş., Albayrak, M., Dağdaş, S., Ceran, F., Özet, G., Demirağ, F., Yokuş, O., "A rare extramedullary involvement in myeloma: Lung parenchyma and association with unfavorable chromosomal abnormalities,” Turk J Hematol, 27(2), 109-12 (2010). (Indexed in SCI-Expanded)

  • Yokuş, O., Balçık, Ö.Ş., Albayrak, M., Ceran, F., Dağdaş, S., Yılmaz, M., Özet, G., "Evaluation of risk factors for thrombophilia in patients with cerebral venous thrombosis," Turk J Hematol, 27(3), 162-7 (2010). (Indexed in SCI-Expanded)

  • Albayrak, M., Balçık, Ö.Ş., Dağdaş, S., Yılmaz, M., Ceran, F., Yokuş, O., Özet, G., "Role of flow cytometry in multiple myeloma and the prognostic significance of CD87 (uPAR) expression,” Turk J Hematol, 27(3), 182-9 (2010). (Indexed in SCI-Expanded)

  • Yokus, O., Albayrak, M., Balcik, O.S., Gokalp, S.S., Ersaydı, M., Akar, M., Tekin, Y., Bozkurt, H.K., "A rare co-incidental presentation: Multiple myeloma and pleural adenocarcinoma – A case report,” International Journal of Hematology and Oncology, 21(2), 106-10 (2011). (Indexed in SCI-Expanded)

  • Kargılı, A., Çipil, H.Ş., Karakurt, F., Kasapoğlu, B., Koca, C., Aydın, M., Uysal, S., İkizek, M., Uz, E., Balçık, O.Ş., Kosar, A., “Hemostatic alterations in fatty liver disease,” Blood Coagul Fibrinolysis, 21(4), 325-7 (2010). (Indexed in SCI/SCI-Expanded)

  • Yokus, O., Balcik, O.S., Albayrak, M., “Patient with megaloblastic anemia, admitted with pancytopenia and walking difficulty, although vitamin B12 and MCV levels were normal,” Pak J Med Sci, 26(3), 736-9 (2010). (Indexed in SCI-Expanded)

  • Uz, E., Alıcı, Ö., Balçık, Ö.Ş., Kanbay, M., Işık, A., Uz, B., Kaya, A., Koşar, A., “Portal vein thrombosis secondary to Klebsiella oxytoca bacteremia,” Turk J Hematol, 27(3), 213-5 (2010). (Indexed in SCI-Expanded)

  • Kosar, A., Kasapoglu, B., Kalyoncu, S., Turan, H., Balcik, O.S., Gümüs, E.I., “Treatment of adverse perinatal outcome in inherited thrombophilias: A clinical study,” Blood Coagul Fibrinolysis, 22(1), 14-8 (2011). (Indexed in SCI/SCI-Expanded)

  • Albayrak, M., Balcik, O.S., Alan, S., Dincer, S.L., Yuksel, M.K., Albayrak, A., “A rare cause of fever, hepatosplenomegaly, and thrombocytopenia: Hepatosplenic gamma/delta T-cell lymphoma,” Pathol Oncol Res, 17, 421-3 (2011). (Indexed in SCI-Expanded)

  • Balcik, O.S., Albayrak, M., Uyar, M.E., Dagdas, S., Yokus, O., Ceran, F., Cipil, H., Kosar, A., Ozet, G., “Serum TAFI Levels in Patients with Newly Diagnosed Multiple Myeloma,” Blood Coagul Fibrinolysis, 22(4), 260–3 (2011). (Indexed in SCI/SCI-Expanded)

  • Albayrak, M., Aksu, S., Celebi, H., Albayrak, A., Ginis, Z., Yagcı, S., Balcik, O.S., Yokus, O., Haznedaroglu, I.C., “Striking Promotion of the in vitro Myeloma Monoclonal Immunoglobulin Aggregation by Ankaferd Hemostat,” International Journal of Hematology and Oncology, 22(1), 15-22 (2012). (Indexed in SCI-Expanded) (Post-Associate Professor)

  • Balcik, O.S., Akdeniz, D., Cipil, H., Uysal, S., Isik, A., Kosar, A., "Heparin Platelet Factor 4 Antibody Positivity In Pseudothrombocytopenia," Clinical and Applied Thrombosis/Hemostasis, 18(1), 92-5 (2012). (Indexed in SCI-Expanded) (Post-Associate Professor)

  • Balcık, O.S., Albayrak, M., Dagdas, S., Helvacı, N., Yokus, O., Ceran, F., Ozet, G., Ergöçen, S., “Conventional cytogenetics and FISH [del13q, del17p, t(11;14), t(4;14)] findings and their relationship with other risk factors in multiple myeloma,” International Journal of Hematology and Oncology, 21(4), 203-9 (2011). (Indexed in SCI-Expanded) (Post-Associate Professor)

  • Yokus, O., Uckurt, Y., Demir, A.S., Kalyon, S., Balcik, O.S., Akdeniz, D., “Antiphospholipid syndrome with hemophilia B: A case report represented by recurrent thrombosis/bleeding attacks,” Pak J Med Sci, 27(4), 922–5 (2011). (Indexed in SCI-Expanded) (Post-Associate Professor)

  • Balcik, O.S., Akdeniz, D., Cipil, H., Ikizek, M., Uysal, S., Kosar, A., Yigitoglu, R., “Thrombopoietin Levels in Patients with Non-Alcoholic Fatty Liver Disease,” Saudi Medical Journal, 33(1), 30-3 (2011). (Indexed in SCI-Expanded) (Post-Associate Professor)

  • Albayrak, M., Celebi, H., Albayrak, A., Sayilir, A., Yesil, Y., Balcik, O.S., Yokus, O., Celik, T., "Elevated Serum Angiotensin-Converting Enzyme Levels as a Reflection of Bone Marrow Renin-Angiotensin System Activation in Multiple Myeloma," Journal of the Renin-Angiotensin-Aldosterone System, 13(2), 259-64 (2012). Epub 2012 Feb 16. (Post-Associate Professor)

  • Isik, A., Balcik, O.S., Akdeniz, D., Cipil, H., Uysal, S., Kosar, A., “Relationship between Some Clinical Situations, Autoantibodies, and Pseudothrombocytopenia,” Clinical and Applied Thrombosis/Hemostasis, 18(6), 645-9 (2012). Epub 2012 Mar 5. (Post-Associate Professor)

  • Balcık, O.S., Koroglu, M., Cipil, H., Kaftan, O., Maral, S., Gurel, A., Goker, H., Haznedaroglu, I.C., Kosar, A., “A Placebo-Controlled, Randomized, Double-Blinded, Cross-Over Phase-I Clinical Study Indicating the Safety of Topical Ankaferd Hemostat in Healthy Volunteers,” International Journal of Hematology and Oncology, 22(4), 267-74 (2012). (Indexed in SCI-Expanded) (Post-Associate Professor)

  • Balcik, O.S., Bilen, S., Ulusoy, E.K., Akdeniz, D., Uysal, S., Ikizek, M., Ak, F., Kosar, A., “Thrombopoetin and Mean Platelet Volume in Patients with Ischemic Stroke,” Clinical and Applied Thrombosis/Hemostasis, 19(1), 92-5 (2013). (Indexed in SCI-Expanded) (Post-Associate Professor)

  • Karataş, S.G., Bayrak, R., Balcik, O.S., Yalcin, K.S., Atici, E., Akyildiz, U., Kosar, A., “HIV Negative HHV-8 Positive Primary Effusion Lymphoma: A Case Report and Review of the Literature,” Turk J Hematol, 30, 67-71 (2013). (Indexed in SCI-Expanded)

  • Balcik, O.S., Aksoy, C., Akdeniz, D., Akkaya, C., Guvenc, B., Dinçer, S., “Comparison of standard and salvage chemotherapy regimens regarding CD34(+) peripheral stem cell harvesting success,” International Journal of Hematology and Oncology, 23(3), 184-192 (2013). (Indexed in SCI-Expanded) (Post-Associate Professor)

  • Ceylan, H., Kocabey, S., Unal Gulsuner, H., Balcik, O.S., Guler, M., Tekinay, A., "Bone-like apatite nucleating nanofibers induce differentiation of human mesenchymal stem cells into mature osteoblasts,” Biomacromolecules, 15(7), 2407-18 (2014).

  • Maral, S., Acar, M., Balcik, O.S., Uctepe, E., Hatipoglu, O.F., Akdeniz, D., Altun, H.U., Kosar, A., Gunduz, M., Gunduz, E., “Matrix Metalloproteinases 2 and 9 Polymorphism in Patients With Myeloproliferative Diseases: A STROBE-Compliant Observational Study,” Medicine (Baltimore), 94(16), e732 (2015). doi: 10.1097/MD.0000000000000732

Articles published in national peer-reviewed journals

  • D1. Balçık, Ö.Ş., "JNC-6 raporuna göre hipertansiyonun tanı ve tedavisi," İlaç ve Tedavi Dergisi.,  12(1), 47-8 (1999).
  • D2. Balçık, Ö.Ş., "Trandolapril diyabetik nöropatiyi geriletiyor," İlaç ve Tedavi Dergisi., 12(2), 122 (1999).
  • D3. Balçık, Ö.Ş., Karaaslan, Y., "Romatoid artritte kombine DMARD kullanımı," İç Hastalıkları Progres., 1(4), 125-9 (2000).
  • D4. Balçık, Ö.Ş., Kaftan, O., "Hiperkolesterolemi ve gode bırakmayan ödem," Yeni Tıp Dergisi., 17(3), 164 (2000).
  • D5. Öztürk, M., Balçık, Ö.Ş., "Olgu tartışması," İç Hastalıkları Progres., 2(4), 134 (2001).
  • D6. Balçık, Ö.Ş., "Akut sinüzitli erişkinlerde antibiyotiklerin uygun kullanımı," İç Hastalıkları Progres., 2(5), 157-8 (2001).
  • D7. Balçık, Ö.Ş., Koçkar, C., Sipahi, N., "Halsizlik, kilo kaybı, çok su içme, çok idrara çıkma," Yeni Tıp Dergisi., 18(4), 217-8 (2001).
  • D8. Balçık, Ö.Ş., "Uzun etkili B2 agonistler: Formoterol ve salmeterolden hangisi daha iyi?," İç Hastalıkları Progres., 2(7), 221-2 (2001).
  • D9. Balçık, Ö.Ş., "Derin ven trombozu," İç Hastalıkları Progres.,  2(7), 229-30 (2001).
  • D10. Balçık, Ö.Ş., "Aşılamanın romatolojik bulguları," İç Hastalıkları Progres., 2(8), 260 (2001).
  • D11. Balçık, Ö.Ş., "Romatolojik hastalıklarda ımmunizasyon," İç Hastalıkları Progres., 2(8), 261 (2001).
  • D12. Balçık, Ö.Ş., Karakuş, S.,  "Primer trombositemi," İç Hastalıkları Progres., 2(12), 372-6 (2001).
  • D13. Balçık, Ö.Ş.,  "İrritabl barsak sendromu," İç Hastalıkları Progres.,  3(5), 149-51 (2002).
  • D14. Balçık, Ö.Ş., "Yeni kolesterol tedavi rehberi (NCEP-ATP III) ışığında günümüzde hiperlipidemi tedavisi," İç Hastalıkları Progres.,  4(1), 12-21 (2003).
  • D15. Balçık, Ö.Ş., Kaftan, O., "Antibiyotiğe bağlı kolitler," İç Hastalıkları Progres.,  4(4), 178-80 (2003).
  • D16. Dagdas, S., Albayrak, M., Balcik, O.S., Ozet, G., Ceran, F., Erekul, S., "A case of multicentric HHV-8 positive Castleman’s disease presenting with marked lymphocytosis," Turkish Journal of Cancer.,  39(3), 110-4 (2009).
  • D17. Balçık, Ö.Ş., Helvacı, N., Albayrak,  M., Yokuş, O., Ceran, F., Dağdaş, S., Özet, G., "Myelodysplastic syndrome with complex cytogenetic abnormalities and immunocompromised in two siblings," Acta Oncologica Turcica., 43, 88-90 (2010).
  • D18. Yokuş, O., Balcık, Ö.Ş., Albayrak, M., “The efficiency and side-effects of low-dose fludarabine-cyclophosphamide in the treatment of chronic lymphocytic leukemia,”  J Clin Exp Invest., 1(1), 63-5 (2010).
  • D19. Yokuş, O., Balcık, Ö.Ş., Albayrak, M., “Diagnosis and treatment strategies of thrombophilic risk factors,”  J Clin Exp Invest., 1(2), 125-33 (2010).
  • D20. Yokuş, O., Kurnaz, F., Balçık, Ö.Ş., Uz, B., Albayrak, M., “Coexistance of JAK2V617F mutation and BCR/ABL translocation in one patient,” J Clin Exp Invest., 1(2), 138-40 (2010).
  • D21. Turgut, F., Çarlıoğlu, A., Alkan, R., Akdeniz, D., Haltaş, H., Balçık, Ö.Ş., Uz, E., Karataş, Ö.F., “Erdosteinin diyabetik ratlarda böbrek hasarı üzerine koruyucu etkisi,” Türk Nefroloji Diyaliz ve Transplantasyon Dergisi., 19(3), 157-61 (2010).
  • D22. Helvacı, M.R., Albayrak, M., Balçık, Ö.Ş., Çelebi, H., Ertekin, F., “Hematocrit value and body mass index,”. Endokrinolojide Yönelişler., 19(5), 131-3 (2010).
  • D23. Albayrak, M., Balcik, O.S., Aki, S.Z., Gokmen, A., Ceran, F., Yokus, O., Dagdas, S., Ayli, M., Ozet, G., “Evaluation of 143 cases with immune thrombocytopenic purpura in the view of clinical course and response to treatment,” The Eurasian Journal of Medicine., 42, 120-3 (2010).
  • D24. Yokuş, O., Balçık, Ö.Ş., Albayrak, M., Ceran, F., Yılmaz, M., Dağdaş, S., Özet, G., “Thrombophilic Risk Factors in Women with Recurrent Abortion,” J Clin Exp Invest., 1(3), 168-72 (2010).
  • D25. Alkan, R., U, E., Balçık, Ö.Ş., Uz, B., Bayram, Y., “Is end-stage renal disease always symptomatic?,” J Clin Exp Invest., 1(3), 216-18 (2010).
  • D26. Balçık, Ö.Ş., Gümüş, İ.İ., Kamalak, Z., Çipil, H., Kaygusuz, İ.Ç., Kosar, A., “Safety of imatinib during pregnancy: Report of two cases and review of literature,” Turkiye Klinikleri J Gynecol Obst., 20(6), 387-91 (2010).
  • D27. Balcık, O.S., Albayrak, M., Dinçer, S.L., Yüksel, M., Pak, I., Çiçek, C., Oymak, A., Çelik, Z., “A Rare Involvement Region In Primary Cutaneous B Cell Lymphoma: Scalp,” Ortadoğu Medical Journal., 2(4), 42-5 (2010).
  • D28. Yokuş, O., Yılmaz, B., Albayrak, M., Balçık, Ö.Ş., Helvacı, M.R., Sennaroğlu, E., "The Significance of Serum Transferrin Receptor in Diagnosis of the Coexistence of Anemia of Chronic Disease and Iron Deficiency Anemia," The Eurasian Journal of Medicine, 43, 9-12 (2011).
  • D29. Yokuş, O., Gökalp, S.S., Balçık, Ö.Ş., Albayrak, M., Ersaydı, M., “Homozigot JAK2 Mutasyonlu Erkek Hastada Karotis Stenozu ve Esansiyel Trombositemi Birlikteliği: Olgu Sunumu,” Fırat Tıp Dergisi., 16(1), 38-40 (2011).
  • D30. Balçık, Ö.Ş., Akkaya, Ç., Uz, B., Aksoy, C., Güvenç, B., Dinçer, S., “The efficacy and safety of hypertonic citrate as catheter-locking solution in hematopoietic stem cell transplant recipients,” Türkiye Klinikleri Cardiovascular Sciences., 23(1), 48-53 (2011).
  • D31. Yılmaz, B., Tunca, H., Balçık, Ö.Ş., Hasa, S.A., Sennaoğlu, E., “Metabolik Sendromlu Kadın Hastalar Ve P Dalga Dispersiyonu,” Ortadoğu Medical Journal., 3(1), 27-31 (2011).
  • D32. Balcik, Ö.S., Albayrak, M., Dağdaş, S., Tamözlü, T., Yokuş, O., Ceran, F., Özet, G., “Familial Myeloproliferative Diseases and JAK2 Mutation: Two Case Reports and Review of Literature,” Ortadoğu Medical Journal., 3(1), 41-4 (2011).

Resume

Education and Specialty Training

  • Ankara University Faculty of Medicine – Medical Education

  • Ankara Numune Training and Research Hospital – Specialty Training in Internal Medicine and Hematology

Professional Experience

  • 2003–2007: Ankara Numune Training and Research Hospital, Hematology

  • 2007–2009: Dr. Abdurrahman Yurtarslan Ankara Oncology Training and Research Hospital, Hematology

  • 2010–2011: Ankara Bayındır Hospital, Bone Marrow Transplant Unit

  • 2011–2016: Turgut Özal University, Hematology

  • 2017–Present: Medical Park Samsun Hospital

Professional Memberships

  • Turkish Society of Internal Medicine Specialists

  • Turkish Society of Hematology

  • Hematology Specialty Association

  • International Society of Hematology

  • European Hematology Association

Publications

Articles Published in International Peer-Reviewed Journals

  • Balçik, O.S., Oztürk, M., Dağli, M., Kaftan, O., Koşar, A., Karaaslan, Y., Kirazli, S., "Increased erythropoietin levels in reactive thrombocytosis,” Haematologia (Budap), 32(1), 59-65 (2002). (Indexed in SCI-Expanded)

  • Kaftan, O., Balcik, O.S., Cipil, H., Ozet, G., Bavbek, N., Koşar, A., Dagdas, S., "Plasma levels of thrombin-activatable fibrinolysis inhibitor in primary and secondary thrombocytosis,” Clin Appl Thromb Hemost, 11(4), 449-54 (2005). (Indexed in SCI-Expanded)

  • Balçık, O.Ş., Dağdaş, S., Güler, S.K., Özet, G., Oymak, A., Çelik, Z., Zengin, N., Öksüzoğlu, B., Aylı, M., Dinçer, S., Albayrak, M., “Effect of autologous peripheral stem cell collection regimens on CD34(+) cell count: Single-center experience,” Turkiye Klinikleri J Med Sci, 28, 640-7 (2008). (Indexed in SCI-Expanded)

  • Yokus, O., Albayrak, M., Balcik, O.S., Ceran, F., Dagdas, S., Yilmaz, M., Ozet, G., "Risk factors for thrombophilia in young adults presenting with thrombosis,” Int J Hematol, 90(5), 583-90 (2009). (Indexed in SCI-Expanded)

  • Aydin, Y., Berker, D., Ustün, I., Balcik, O., Balli, D.N., Delibasi, T., Peksoy, I., Guler, S., "A very rare cause of aplastic anemia: Graves disease,” South Med J, 101(6), 666-7 (2008). (Indexed in SCI-Expanded)

  • Balçık, Ö.Ş., Dağdaş, S., Albayrak, M., Efe, C., Yokuş, O., Ceran, F., Özet, G., Yılmaz, M., Albayrak, L., "Development of multiple myeloma during chronic lymphocytic leukemia: Case report,” International Journal of Hematology and Oncology, 18(4), 238-41 (2008). (Indexed in SCI-Expanded)

  • Balçık, Ö.Ş., Albayrak, M., Dağdaş, S., Ceran, F., Özet, G., Demirağ, F., Yokuş, O., "A rare extramedullary involvement in myeloma: Lung parenchyma and association with unfavorable chromosomal abnormalities,” Turk J Hematol, 27(2), 109-12 (2010). (Indexed in SCI-Expanded)

  • Yokuş, O., Balçık, Ö.Ş., Albayrak, M., Ceran, F., Dağdaş, S., Yılmaz, M., Özet, G., "Evaluation of risk factors for thrombophilia in patients with cerebral venous thrombosis," Turk J Hematol, 27(3), 162-7 (2010). (Indexed in SCI-Expanded)

  • Albayrak, M., Balçık, Ö.Ş., Dağdaş, S., Yılmaz, M., Ceran, F., Yokuş, O., Özet, G., "Role of flow cytometry in multiple myeloma and the prognostic significance of CD87 (uPAR) expression,” Turk J Hematol, 27(3), 182-9 (2010). (Indexed in SCI-Expanded)

  • Yokus, O., Albayrak, M., Balcik, O.S., Gokalp, S.S., Ersaydı, M., Akar, M., Tekin, Y., Bozkurt, H.K., "A rare co-incidental presentation: Multiple myeloma and pleural adenocarcinoma – A case report,” International Journal of Hematology and Oncology, 21(2), 106-10 (2011). (Indexed in SCI-Expanded)

  • Kargılı, A., Çipil, H.Ş., Karakurt, F., Kasapoğlu, B., Koca, C., Aydın, M., Uysal, S., İkizek, M., Uz, E., Balçık, O.Ş., Kosar, A., “Hemostatic alterations in fatty liver disease,” Blood Coagul Fibrinolysis, 21(4), 325-7 (2010). (Indexed in SCI/SCI-Expanded)

  • Yokus, O., Balcik, O.S., Albayrak, M., “Patient with megaloblastic anemia, admitted with pancytopenia and walking difficulty, although vitamin B12 and MCV levels were normal,” Pak J Med Sci, 26(3), 736-9 (2010). (Indexed in SCI-Expanded)

  • Uz, E., Alıcı, Ö., Balçık, Ö.Ş., Kanbay, M., Işık, A., Uz, B., Kaya, A., Koşar, A., “Portal vein thrombosis secondary to Klebsiella oxytoca bacteremia,” Turk J Hematol, 27(3), 213-5 (2010). (Indexed in SCI-Expanded)

  • Kosar, A., Kasapoglu, B., Kalyoncu, S., Turan, H., Balcik, O.S., Gümüs, E.I., “Treatment of adverse perinatal outcome in inherited thrombophilias: A clinical study,” Blood Coagul Fibrinolysis, 22(1), 14-8 (2011). (Indexed in SCI/SCI-Expanded)

  • Albayrak, M., Balcik, O.S., Alan, S., Dincer, S.L., Yuksel, M.K., Albayrak, A., “A rare cause of fever, hepatosplenomegaly, and thrombocytopenia: Hepatosplenic gamma/delta T-cell lymphoma,” Pathol Oncol Res, 17, 421-3 (2011). (Indexed in SCI-Expanded)

  • Balcik, O.S., Albayrak, M., Uyar, M.E., Dagdas, S., Yokus, O., Ceran, F., Cipil, H., Kosar, A., Ozet, G., “Serum TAFI Levels in Patients with Newly Diagnosed Multiple Myeloma,” Blood Coagul Fibrinolysis, 22(4), 260–3 (2011). (Indexed in SCI/SCI-Expanded)

  • Albayrak, M., Aksu, S., Celebi, H., Albayrak, A., Ginis, Z., Yagcı, S., Balcik, O.S., Yokus, O., Haznedaroglu, I.C., “Striking Promotion of the in vitro Myeloma Monoclonal Immunoglobulin Aggregation by Ankaferd Hemostat,” International Journal of Hematology and Oncology, 22(1), 15-22 (2012). (Indexed in SCI-Expanded) (Post-Associate Professor)

  • Balcik, O.S., Akdeniz, D., Cipil, H., Uysal, S., Isik, A., Kosar, A., "Heparin Platelet Factor 4 Antibody Positivity In Pseudothrombocytopenia," Clinical and Applied Thrombosis/Hemostasis, 18(1), 92-5 (2012). (Indexed in SCI-Expanded) (Post-Associate Professor)

  • Balcık, O.S., Albayrak, M., Dagdas, S., Helvacı, N., Yokus, O., Ceran, F., Ozet, G., Ergöçen, S., “Conventional cytogenetics and FISH [del13q, del17p, t(11;14), t(4;14)] findings and their relationship with other risk factors in multiple myeloma,” International Journal of Hematology and Oncology, 21(4), 203-9 (2011). (Indexed in SCI-Expanded) (Post-Associate Professor)

  • Yokus, O., Uckurt, Y., Demir, A.S., Kalyon, S., Balcik, O.S., Akdeniz, D., “Antiphospholipid syndrome with hemophilia B: A case report represented by recurrent thrombosis/bleeding attacks,” Pak J Med Sci, 27(4), 922–5 (2011). (Indexed in SCI-Expanded) (Post-Associate Professor)

  • Balcik, O.S., Akdeniz, D., Cipil, H., Ikizek, M., Uysal, S., Kosar, A., Yigitoglu, R., “Thrombopoietin Levels in Patients with Non-Alcoholic Fatty Liver Disease,” Saudi Medical Journal, 33(1), 30-3 (2011). (Indexed in SCI-Expanded) (Post-Associate Professor)

  • Albayrak, M., Celebi, H., Albayrak, A., Sayilir, A., Yesil, Y., Balcik, O.S., Yokus, O., Celik, T., "Elevated Serum Angiotensin-Converting Enzyme Levels as a Reflection of Bone Marrow Renin-Angiotensin System Activation in Multiple Myeloma," Journal of the Renin-Angiotensin-Aldosterone System, 13(2), 259-64 (2012). Epub 2012 Feb 16. (Post-Associate Professor)

  • Isik, A., Balcik, O.S., Akdeniz, D., Cipil, H., Uysal, S., Kosar, A., “Relationship between Some Clinical Situations, Autoantibodies, and Pseudothrombocytopenia,” Clinical and Applied Thrombosis/Hemostasis, 18(6), 645-9 (2012). Epub 2012 Mar 5. (Post-Associate Professor)

  • Balcık, O.S., Koroglu, M., Cipil, H., Kaftan, O., Maral, S., Gurel, A., Goker, H., Haznedaroglu, I.C., Kosar, A., “A Placebo-Controlled, Randomized, Double-Blinded, Cross-Over Phase-I Clinical Study Indicating the Safety of Topical Ankaferd Hemostat in Healthy Volunteers,” International Journal of Hematology and Oncology, 22(4), 267-74 (2012). (Indexed in SCI-Expanded) (Post-Associate Professor)

  • Balcik, O.S., Bilen, S., Ulusoy, E.K., Akdeniz, D., Uysal, S., Ikizek, M., Ak, F., Kosar, A., “Thrombopoetin and Mean Platelet Volume in Patients with Ischemic Stroke,” Clinical and Applied Thrombosis/Hemostasis, 19(1), 92-5 (2013). (Indexed in SCI-Expanded) (Post-Associate Professor)

  • Karataş, S.G., Bayrak, R., Balcik, O.S., Yalcin, K.S., Atici, E., Akyildiz, U., Kosar, A., “HIV Negative HHV-8 Positive Primary Effusion Lymphoma: A Case Report and Review of the Literature,” Turk J Hematol, 30, 67-71 (2013). (Indexed in SCI-Expanded)

  • Balcik, O.S., Aksoy, C., Akdeniz, D., Akkaya, C., Guvenc, B., Dinçer, S., “Comparison of standard and salvage chemotherapy regimens regarding CD34(+) peripheral stem cell harvesting success,” International Journal of Hematology and Oncology, 23(3), 184-192 (2013). (Indexed in SCI-Expanded) (Post-Associate Professor)

  • Ceylan, H., Kocabey, S., Unal Gulsuner, H., Balcik, O.S., Guler, M., Tekinay, A., "Bone-like apatite nucleating nanofibers induce differentiation of human mesenchymal stem cells into mature osteoblasts,” Biomacromolecules, 15(7), 2407-18 (2014).

  • Maral, S., Acar, M., Balcik, O.S., Uctepe, E., Hatipoglu, O.F., Akdeniz, D., Altun, H.U., Kosar, A., Gunduz, M., Gunduz, E., “Matrix Metalloproteinases 2 and 9 Polymorphism in Patients With Myeloproliferative Diseases: A STROBE-Compliant Observational Study,” Medicine (Baltimore), 94(16), e732 (2015). doi: 10.1097/MD.0000000000000732

Articles published in national peer-reviewed journals

  • D1. Balçık, Ö.Ş., "JNC-6 raporuna göre hipertansiyonun tanı ve tedavisi," İlaç ve Tedavi Dergisi.,  12(1), 47-8 (1999).
  • D2. Balçık, Ö.Ş., "Trandolapril diyabetik nöropatiyi geriletiyor," İlaç ve Tedavi Dergisi., 12(2), 122 (1999).
  • D3. Balçık, Ö.Ş., Karaaslan, Y., "Romatoid artritte kombine DMARD kullanımı," İç Hastalıkları Progres., 1(4), 125-9 (2000).
  • D4. Balçık, Ö.Ş., Kaftan, O., "Hiperkolesterolemi ve gode bırakmayan ödem," Yeni Tıp Dergisi., 17(3), 164 (2000).
  • D5. Öztürk, M., Balçık, Ö.Ş., "Olgu tartışması," İç Hastalıkları Progres., 2(4), 134 (2001).
  • D6. Balçık, Ö.Ş., "Akut sinüzitli erişkinlerde antibiyotiklerin uygun kullanımı," İç Hastalıkları Progres., 2(5), 157-8 (2001).
  • D7. Balçık, Ö.Ş., Koçkar, C., Sipahi, N., "Halsizlik, kilo kaybı, çok su içme, çok idrara çıkma," Yeni Tıp Dergisi., 18(4), 217-8 (2001).
  • D8. Balçık, Ö.Ş., "Uzun etkili B2 agonistler: Formoterol ve salmeterolden hangisi daha iyi?," İç Hastalıkları Progres., 2(7), 221-2 (2001).
  • D9. Balçık, Ö.Ş., "Derin ven trombozu," İç Hastalıkları Progres.,  2(7), 229-30 (2001).
  • D10. Balçık, Ö.Ş., "Aşılamanın romatolojik bulguları," İç Hastalıkları Progres., 2(8), 260 (2001).
  • D11. Balçık, Ö.Ş., "Romatolojik hastalıklarda ımmunizasyon," İç Hastalıkları Progres., 2(8), 261 (2001).
  • D12. Balçık, Ö.Ş., Karakuş, S.,  "Primer trombositemi," İç Hastalıkları Progres., 2(12), 372-6 (2001).
  • D13. Balçık, Ö.Ş.,  "İrritabl barsak sendromu," İç Hastalıkları Progres.,  3(5), 149-51 (2002).
  • D14. Balçık, Ö.Ş., "Yeni kolesterol tedavi rehberi (NCEP-ATP III) ışığında günümüzde hiperlipidemi tedavisi," İç Hastalıkları Progres.,  4(1), 12-21 (2003).
  • D15. Balçık, Ö.Ş., Kaftan, O., "Antibiyotiğe bağlı kolitler," İç Hastalıkları Progres.,  4(4), 178-80 (2003).
  • D16. Dagdas, S., Albayrak, M., Balcik, O.S., Ozet, G., Ceran, F., Erekul, S., "A case of multicentric HHV-8 positive Castleman’s disease presenting with marked lymphocytosis," Turkish Journal of Cancer.,  39(3), 110-4 (2009).
  • D17. Balçık, Ö.Ş., Helvacı, N., Albayrak,  M., Yokuş, O., Ceran, F., Dağdaş, S., Özet, G., "Myelodysplastic syndrome with complex cytogenetic abnormalities and immunocompromised in two siblings," Acta Oncologica Turcica., 43, 88-90 (2010).
  • D18. Yokuş, O., Balcık, Ö.Ş., Albayrak, M., “The efficiency and side-effects of low-dose fludarabine-cyclophosphamide in the treatment of chronic lymphocytic leukemia,”  J Clin Exp Invest., 1(1), 63-5 (2010).
  • D19. Yokuş, O., Balcık, Ö.Ş., Albayrak, M., “Diagnosis and treatment strategies of thrombophilic risk factors,”  J Clin Exp Invest., 1(2), 125-33 (2010).
  • D20. Yokuş, O., Kurnaz, F., Balçık, Ö.Ş., Uz, B., Albayrak, M., “Coexistance of JAK2V617F mutation and BCR/ABL translocation in one patient,” J Clin Exp Invest., 1(2), 138-40 (2010).
  • D21. Turgut, F., Çarlıoğlu, A., Alkan, R., Akdeniz, D., Haltaş, H., Balçık, Ö.Ş., Uz, E., Karataş, Ö.F., “Erdosteinin diyabetik ratlarda böbrek hasarı üzerine koruyucu etkisi,” Türk Nefroloji Diyaliz ve Transplantasyon Dergisi., 19(3), 157-61 (2010).
  • D22. Helvacı, M.R., Albayrak, M., Balçık, Ö.Ş., Çelebi, H., Ertekin, F., “Hematocrit value and body mass index,”. Endokrinolojide Yönelişler., 19(5), 131-3 (2010).
  • D23. Albayrak, M., Balcik, O.S., Aki, S.Z., Gokmen, A., Ceran, F., Yokus, O., Dagdas, S., Ayli, M., Ozet, G., “Evaluation of 143 cases with immune thrombocytopenic purpura in the view of clinical course and response to treatment,” The Eurasian Journal of Medicine., 42, 120-3 (2010).
  • D24. Yokuş, O., Balçık, Ö.Ş., Albayrak, M., Ceran, F., Yılmaz, M., Dağdaş, S., Özet, G., “Thrombophilic Risk Factors in Women with Recurrent Abortion,” J Clin Exp Invest., 1(3), 168-72 (2010).
  • D25. Alkan, R., U, E., Balçık, Ö.Ş., Uz, B., Bayram, Y., “Is end-stage renal disease always symptomatic?,” J Clin Exp Invest., 1(3), 216-18 (2010).
  • D26. Balçık, Ö.Ş., Gümüş, İ.İ., Kamalak, Z., Çipil, H., Kaygusuz, İ.Ç., Kosar, A., “Safety of imatinib during pregnancy: Report of two cases and review of literature,” Turkiye Klinikleri J Gynecol Obst., 20(6), 387-91 (2010).
  • D27. Balcık, O.S., Albayrak, M., Dinçer, S.L., Yüksel, M., Pak, I., Çiçek, C., Oymak, A., Çelik, Z., “A Rare Involvement Region In Primary Cutaneous B Cell Lymphoma: Scalp,” Ortadoğu Medical Journal., 2(4), 42-5 (2010).
  • D28. Yokuş, O., Yılmaz, B., Albayrak, M., Balçık, Ö.Ş., Helvacı, M.R., Sennaroğlu, E., "The Significance of Serum Transferrin Receptor in Diagnosis of the Coexistence of Anemia of Chronic Disease and Iron Deficiency Anemia," The Eurasian Journal of Medicine, 43, 9-12 (2011).
  • D29. Yokuş, O., Gökalp, S.S., Balçık, Ö.Ş., Albayrak, M., Ersaydı, M., “Homozigot JAK2 Mutasyonlu Erkek Hastada Karotis Stenozu ve Esansiyel Trombositemi Birlikteliği: Olgu Sunumu,” Fırat Tıp Dergisi., 16(1), 38-40 (2011).
  • D30. Balçık, Ö.Ş., Akkaya, Ç., Uz, B., Aksoy, C., Güvenç, B., Dinçer, S., “The efficacy and safety of hypertonic citrate as catheter-locking solution in hematopoietic stem cell transplant recipients,” Türkiye Klinikleri Cardiovascular Sciences., 23(1), 48-53 (2011).
  • D31. Yılmaz, B., Tunca, H., Balçık, Ö.Ş., Hasa, S.A., Sennaoğlu, E., “Metabolik Sendromlu Kadın Hastalar Ve P Dalga Dispersiyonu,” Ortadoğu Medical Journal., 3(1), 27-31 (2011).
  • D32. Balcik, Ö.S., Albayrak, M., Dağdaş, S., Tamözlü, T., Yokuş, O., Ceran, F., Özet, G., “Familial Myeloproliferative Diseases and JAK2 Mutation: Two Case Reports and Review of Literature,” Ortadoğu Medical Journal., 3(1), 41-4 (2011).

Call Center
and book your appointment instantly.
444 44 84

Thank You

We will contact you as soon as possible. We wish you healthy days!